The Alderley Park Lighthouse Lab, which was launched to rapidly expand COVID-19 testing capacity, has processed more than 1 million test samples since opening.
Consortia are enabling drug discovery in areas that individual organizations are unable to support alone because of the high risk or the need to pool information.
The Psychiatry Consortium is again seeking project proposals which focus on the validation of novel molecular drug-targets.
This week the Medicines Discovery Catapult has welcomed three new Board Members.
Medicines Discovery Catapult, Retrogenix and Peak Proteins collaborate to identify target receptors for COVID-19.
Sites in Milton Keynes, Glasgow and Alderley Park in Cheshire are now live and are already testing thousands of patient samples for coronavirus (COVID-19) each day.
The second mega-lab at Alderley Park in Cheshire has begun to test thousands of patient samples a day for coronavirus.
The Government announced the establishment of large scale national COVID-19 hub laboratories across the UK.
The Hearing Medicines Discovery Syndicate and Boehringer Ingelheim today announced a Boehringer Ingelheim Office Hours dedicated to Hearing Loss.
To celebrate British Science Week, Medicines Discovery Catapult have brought their most experienced scientists together with their newest scientists to talk about their motivations to get into drug discovery, as well as the future of the field.
See how we can help support you with your next drug discovery project.
Speak to us